SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 0.86 millions, down -72.17% for the March 2025 quarter as against Rs. 3.09 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -1.65 millions as compared to Net Loss of Rs. -41.44 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 improved to -1.62% as compared to -30.53% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.86 3.09 -72.17 3.83 22.85 -83.24 3.83 22.85 -83.24
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.62 -30.53 -94.69 -8.41 -63.64 -86.79 -8.41 -63.64 -86.79
Interest 0.00 0.76 -100.00 0.03 4.82 -99.38 0.03 4.82 -99.38
PBDT -1.62 -31.29 -94.82 -8.25 -68.47 -87.95 -8.25 -68.47 -87.95
Depreciation 0.00 0.48 0.00 0.12 2.28 -94.74 0.12 2.28 -94.74
PBT -1.62 -31.77 -94.90 -8.37 -70.75 -88.17 -8.37 -70.75 -88.17
TAX 0.03 9.67 -99.69 0.09 9.66 -99.07 0.09 9.66 -99.07
Deferred Tax 0.03 -3.27 -100.92 0.09 -3.28 -102.74 0.09 -3.28 -102.74
PAT -1.65 -41.44 -96.02 -8.46 -80.41 -89.48 -8.46 -80.41 -89.48
Equity 81.31 81.31 0.00 81.31 81.31 0.00 81.31 81.31 0.00
PBIDTM(%) -188.37 -988.03 -80.93 -219.58 -278.51 -21.16 -219.58 -278.51 -21.16

Ortin Global Share Price

14.39 0.68 (4.96%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×